Abstract:The reason(s) underpinning the strong association between cannabis use disorder (CanUD) and schizophrenia remains a passionately debated issue in psychiatry. Does cannabis use increase the risk for schizophrenia, or does schizophrenia promote cannabis use? Or could there be a shared liability, due to common genetic and environmental factors, that explains why these disorders so frequently co-occur? To shed light on this debate, Johnson and colleagues [1] investigated the role of tobacco use, which is strikingly common among people with schizophrenia and those with CanUD. As substance use disorder contributes to the reduced life expectancy in people with schizophrenia, and as more jurisdictions move toward cannabis legalization, finding answers to these questions is more important than ever. Twin-based heritability estimates for CanUD and schizophrenia are ~50% and ~80%, respectively, indicating a strong genetic underpinning. Similarly, tobacco smoking is highly heritable (~50% [2]). In support of a shared liability, large genome-wide association studies (GWASs) of CanUD, schizophrenia, and tobacco smoking have identified several shared loci [3, 4], yet few studies have investigated the genetic interplay between the three traits. Mendelian Randomization (MR), a causal inference approach in which genetic information is used to 'randomize' individuals to an 'exposure', has brought us a step closer in understanding potential causal links. With MR, hypotheses in both directions can be tested (i.e. does CanUD cause schizophrenia, and/or does schizophrenia cause CanUD?). Results from MR studies have been mixed, however, with some showing greater support for schizophrenia causing CanUD, and others providing support for reciprocal causal effects (i.e. CanUD may also cause schizophrenia). To extend this work, Johnson and colleagues [1] used a suite of analytic techniques to disentangle genomic risk factors, and unveil potential causal relationships, between CanUD, schizophrenia, and tobacco smoking.

Genome-wide Identification of the Shared Genetic Basis of Cannabis and Cigarette Smoking and Schizophrenia Implicates NCAM1 and Neuronal Abnormality.

Cigarette Smoking and Schizophrenia: Mendelian Randomisation Study.

Identification of 34 genes conferring genetic and pharmacological risk for the comorbidity of schizophrenia and smoking behaviors

Cross-ancestry genetic investigation of schizophrenia, cannabis use disorder, and tobacco smoking

Cracking the chicken and egg problem of schizophrenia and substance use: Genetic interplay between schizophrenia, cannabis use disorder, and tobacco smoking

Analyzing the Genes Related to Nicotine Addiction or Schizophrenia Via a Pathway and Network Based Approach

Genome-wide Association Studies for Identifying Genetic Architecture of SGRQ in Smoking Population

Neurogenetic underpinnings of nicotine use severity: Integrating the brain transcriptomes and GWAS variants via network approaches

Determination of shared genetic etiology and possible causal relations between tobacco smoking and depression

Characterising the shared genetic determinants of bipolar disorder, schizophrenia and risk-taking

A multi-ancestry cerebral cortex transcriptome-wide association study identifies genes associated with smoking behaviors

Genetic correlation and causality between smoking and 42 neuropsychiatric and gastrointestinal diseases

Smoking-informed methylation and expression QTLs in human brain and colocalization with smoking-associated genetic loci

Acsl6 is Associated with the Number of Cigarettes Smoked and Its Expression is Altered by Chronic Nicotine Exposure

Common and Unique Biological Pathways Associated with Smoking Initiation/progression, Nicotine Dependence, and Smoking Cessation.

S003329172000272Xjra 968..978

Dissecting the genetic overlap of smoking behaviors, lung cancer, and chronic obstructive pulmonary disease: A focus on nicotinic receptors and nicotine metabolizing enzyme

GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability

Genetic overlap between schizophrenia and cognitive performance